• No results found

[PDF] Top 20 How To Treat A Patient With A Lung Condition

Has 10000 "How To Treat A Patient With A Lung Condition" found on our website. Below are the top 20 most common "How To Treat A Patient With A Lung Condition".

How To Treat A Patient With A Lung Condition

How To Treat A Patient With A Lung Condition

... Please note-this guidelines applies to the acute use of BiPAP. From time to time patients on long term non invasive ventilation will be admitted acutely for other reasons. The primary reason for their admission should ... See full document

11

Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?

Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?

... treated with NAT for at least 1 year, were included in data analysis. Four months after NAT discontinuation, lympho- cyte counts, alpha4-integrin saturation, soluble vascular cell adhesion protein, and CD49d expression ... See full document

9

Clozapine: Treat the Patient or Treat the Level?

Clozapine: Treat the Patient or Treat the Level?

... clozapine:norclozapine ratio in relation to prescribed dose and other factors: Data from a Therapeutic Drug Monitoring and other factors: Data from a Therapeutic Drug Monitoring servic[r] ... See full document

23

Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline

Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline

... the patient is allergic to penicillin and because the group A streptococci are showing resistance to erythromycin, a lincosamide such as clindamycin could be ... See full document

12

Opioid Prescribing in IBD and IBS patients

Opioid Prescribing in IBD and IBS patients

... How would the following patient characteristics affect your decision to prescribe opioids to treat IBS-related pain?. (Programmer: Randomize the list)?[r] ... See full document

9

<p>Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report</p>

<p>Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report</p>

... the patient had received multiline treat- ments and the brain metastasis was still progressing, afa- tinib still reached a good therapeutic effect, almost eliminated brain ... See full document

6

A case of a patient with severe epidermolysis bullosa surviving to adulthood

A case of a patient with severe epidermolysis bullosa surviving to adulthood

... and treat anemia, albumin to treat hypoalbumin- emia, and antihypoxic effect with actovegin which normalizes pH, promotes blood circulation, intensifies energy-intensive processes of regeneration and ... See full document

9

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

... Head and neck squamous cell carcinomas (HNSCCs) are a heterogeneous group of diseases with a biologically aggressive nature. Palliative chemotherapy remains the standard of care treatment in the metastatic setting, and ... See full document

5

How To Treat Sud

How To Treat Sud

... To ensure effective treatment, there should be a good dialog between the SD patient and their doctor. Completing a botulinum toxin Information and Tracking Chart is useful. A decision will be made regarding dosage ... See full document

6

Nalfurafine hydrochloride to treat pruritus: a review

Nalfurafine hydrochloride to treat pruritus: a review

... In this study, nighttime pruritus was monitored by the Shiratori severity score (patient assessment). The mean decrease of this score was 0.97, 1.55, and 1.57 at week 2, 24 and 52, respectively, indicating ... See full document

7

Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat

Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat

... Understanding the molecular basis of tumorigenesis and progression can lead to both identification of biomarkers and targets for therapy. Advances in high-throughput tech- nology have demonstrated an ability to ... See full document

5

How To Treat An Arrhythmia

How To Treat An Arrhythmia

... explain how many tablets you need to take and any likely or possible side-eff ects that you might ...from patient to patient, but as a general rule the more potent a drug the more likely it is to ... See full document

16

&lt;p&gt;Practical approach to a patient with chronic pain of uncertain etiology in primary care&lt;/p&gt;

<p>Practical approach to a patient with chronic pain of uncertain etiology in primary care</p>

... complex condition in fl uenced by structural and physiolo- gical changes in the peripheral and central nervous systems, and it directly in fl uences, and is modulated by, psychological well-being and personality ... See full document

12

&lt;p&gt;Response and acquired resistance to savolitinib in a patient with pulmonary sarcomatoid carcinoma harboring &lt;em&gt;MET&lt;/em&gt; exon 14 skipping mutation: a case report&lt;/p&gt;

<p>Response and acquired resistance to savolitinib in a patient with pulmonary sarcomatoid carcinoma harboring <em>MET</em> exon 14 skipping mutation: a case report</p>

... before treat- ment and at the disease ...a patient with MET exon 14 skipping mutation who experienced durable tumor response with cabozantinib treatment after disease progression on crizotionib has recently ... See full document

6

&lt;p&gt;Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring &lt;em&gt;ALK&lt;/em&gt; G1202R Mutation and &lt;em&gt;LIPI-NTRK1&lt;/em&gt; Rearrangement&lt;/p&gt;

<p>Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring <em>ALK</em> G1202R Mutation and <em>LIPI-NTRK1</em> Rearrangement</p>

... non-small-cell lung cancer (NSCLC) patients, de fi ning a speci fi c molecular ...to treat metastatic ALK+ NSCLC patients who have progressed on or are intolerant of ... See full document

5

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer

... 38-year-old patient with LS-related metastatic colon cancer treated in Chile with immuno- therapy ...The patient exhibited a pathogenic deletion in Epithelial cell Adhesion Molecule (EPCAM) and mutS homolog ... See full document

6

Neck Dissection Complications: Chylous Fistula
and a New Conservative Management

Neck Dissection Complications: Chylous Fistula and a New Conservative Management

... the patient continued with Negative Pressure Therapy and antibiotics; from cervical drainage there were collected 830-850 ml of serous liquid / ...General condition of the patient could not support a ... See full document

5

How To Treat An Addiction

How To Treat An Addiction

... Cognitive Behavioral Therapy (CBT) – teaches practical skills and strategies to help people reframe negative self-talk, cope more effectively with cravings and break habits that lead to addiction relapse. The emphasis in ... See full document

14

Development of a questionnaire to assess patient satisfaction with allergen-specific immunotherapy in adults: item generation, item reduction, and preliminary validation

Development of a questionnaire to assess patient satisfaction with allergen-specific immunotherapy in adults: item generation, item reduction, and preliminary validation

... The principal component analysis done on the 16 retained items yielded a good factorial solution, identifying four fac- tors, the items for which were reasonably well grouped with regard to their content and the ... See full document

12

Patients with H-IMR to Phenanthrenes (N=190) Administrations

Patients with H-IMR to Phenanthrenes (N=190) Administrations

... the patient/family is not able to provide further detail. How likely are you to prescribe/verify/administer another opioid agent to this patient (assuming they present with a condition that ... See full document

6

Show all 10000 documents...